Jerzy Adamski is a medicinal scientists and worldwide renowned expert in endocrinology and metabolomics. He has been working in the field of endocrine-related cancers and frequent human diseases like diabetes for 20 years. He published 463 papers (e.g. Nature Genetics, 2010; Nature 2011 and 2020; Nature Reviews in Nephrology, 2017; Cell, 2018, 2021 and 2023, Nature Biotechnology 2023) holds several patents and has H-index of 79. He acts as an Editor-in-Chief for J. Steroid Biochemistry and Molecular Biology. He developed prototypes for early diagnosis of endometriosis, diabetes type 2, kidney dysfunction and cardiovascular complications. He recently co-founded a biotech company Metaron Diagnostics where he acts as CSO. At Metaron Diagnostics he implements validated assays for diagnostics of complex human diseases by metabolomics. His further interests lie in networking and team building for the efficient problem solutions in biomedical discovery and applications in personalized medicine.